Mouad Hamzaoui - Publications

Artificial intelligence in presymptomatic neurological diseases: Bridging normal variation and prodromal signatures.

Journal: Revue neurologique

Published: May 22, 2025

Chronic endothelial dopamine receptor stimulation improves endothelial function and hemodynamics in autosomal dominant polycystic kidney disease.

Journal: Kidney international

Published: September 29, 2023

Cardio-renal syndrome: what’s new in 2023?

Journal: Nephrologie & therapeutique

Published: April 26, 2023

Endothelium-Specific Deficiency of Polycystin-1 Promotes Hypertension and Cardiovascular Disorders.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: September 12, 2022

Priming of Cardiopulmonary Bypass with Human Albumin Decreases Endothelial Dysfunction after Pulmonary Ischemia-Reperfusion in an Animal Model.

Journal: International journal of molecular sciences

Published: July 19, 2022

Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2): a retrospective cohort study.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: October 06, 2021

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.

Journal: Kidney international

Published: July 20, 2021

SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19.

Journal: Transplantation direct

Published: July 07, 2021

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients.

Journal: Clinical kidney journal

Published: May 31, 2021

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.

Journal: Journal of the American Society of Nephrology : JASN

Published: April 08, 2021

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome.

Journal: Frontiers in molecular biosciences

Published: September 08, 2020

Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients.

Journal: Scientific reports

Published: August 14, 2020